72 related articles for article (PubMed ID: 17557246)
1. [Study on the relationship between the polymorphism of p53 gene intron 7 and non-small cell lung cancer (NSCLC) and p53 mutation in NSCLC tissues].
Gu QH; Chen Q; Hu CP; Li YQ; Yang HZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):319-21. PubMed ID: 17557246
[TBL] [Abstract][Full Text] [Related]
2. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Donati V; Fontanini G
Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Fontanini G
Oncol Rep; 2008 Mar; 19(3):771-3. PubMed ID: 18288414
[TBL] [Abstract][Full Text] [Related]
4. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
5. p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.
Yamashita SI; Masuda Y; Yoshida N; Matsuzaki H; Kurizaki T; Haga Y; Ikei S; Miyawaki M; Kawano Y; Chujyo M; Kawahara K
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):148-51. PubMed ID: 17851056
[TBL] [Abstract][Full Text] [Related]
6. [An analysis of two polymorphic points of the 7th intron of human p53 gene].
Gu Q; Shu C; Ye A; Lu X; Tang X; Kuang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):161-3. PubMed ID: 10837515
[TBL] [Abstract][Full Text] [Related]
7. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
8. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.
Chen QL; Zheng WL; Yao WJ; Nie LW; Cheng SH; Ma WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):505-9. PubMed ID: 17922414
[TBL] [Abstract][Full Text] [Related]
9. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
Hsieh YS; Lee YL; Yang SF; Yang JS; Chen W; Chen SC; Shih CM
Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations in non-small cell lung cancer from Thai patients.
Petmitr S; Makthiengtrong S; Sutinont P; Migasena P
J Med Assoc Thai; 1999 Mar; 82(3):250-5. PubMed ID: 10410479
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphism of gene p53 and apoptosis in patients with malignant lung disease--our observation].
Sauka C; Kohút A; Kundrát I; Janík M
Klin Onkol; 2008; 21(3):98-103. PubMed ID: 19097418
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
13. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
14. p53 genotypes and haplotypes associated with risk of breast cancer.
Buyru N; Altinisik J; Demokan S; Dalay N
Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.
Høgdall EV; Kjaer SK; Glud E; Christensen L; Blaakaer J; Vuust J; Bock JE; Norgaard-Pedersen B; Hogdall CK
Anticancer Res; 2003; 23(4):3397-404. PubMed ID: 12926080
[TBL] [Abstract][Full Text] [Related]
16. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
17. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of detection of p53 gene mutation in patients with lung cancer].
Chen Y; Cai Y; Liu L; Wang A; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Nov; 25(11):667-9. PubMed ID: 12490121
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with human small aggressive non small cell lung cancer.
Tammemagi CM; Freedman MT; Church TR; Oken MM; Hocking WG; Kvale PA; Hu P; Riley TL; Ragard LR; Prorok PC; Berg CD
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2082-9. PubMed ID: 17932357
[TBL] [Abstract][Full Text] [Related]
20. Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis.
Smith GD; Chadwick BE; Willmore-Payne C; Bentz JS
J Clin Pathol; 2008 Apr; 61(4):487-93. PubMed ID: 17908804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
